ONTTF Stock Chart & Stats
$1.47
-$0.03(-2.17%)
At close: 4:00 PM EDT
$1.47
-$0.03(-2.17%)
Day’s Range― - ―
52-Week Range$1.27 - $3.11
Previous CloseN/A
Volume44.82K
Average Volume (3M)N/A
Market Cap
$1.64B
Enterprise Value$1.02K
Total Cash (Recent Filing)$255.30M
Total Debt (Recent Filing)$41.50M
Price to Earnings (P/E)―
Beta1.05
Next Earnings
Aug 19, 2026EPS Estimate
-0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding975,364,100
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio1.37
Price to Book (P/B)2.66
Price to Sales (P/S)5.51
P/FCF Ratio-18.61
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$2.60Price Target Upside76.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)$3.57M
Bulls Say, Bears Say
Bulls Say
Broad Revenue Growth And Applied-Market ExpansionStrong, broad-based growth and faster expansion in clinical and industrial applications indicate increasing platform adoption beyond research markets, supporting a more diversified and potentially higher-value recurring consumables base.
Improving Gross Margins And Cost DisciplineHigher margins combined with tightly controlled operating expenses improve the scalability of the instrument-and-consumables model. The FY26 62% margin target suggests further structural operating leverage if product mix and manufacturing initiatives continue.
Conservative Leverage And Significant Cash ResourcesMinimal leverage reduces refinancing pressure and gives Oxford Nanopore capacity to fund product development, commercial expansion and restructuring while pursuing breakeven. The cash reserve provides a meaningful buffer despite ongoing operating losses.
Bears Say
Persistent Losses And Negative Cash GenerationThe company still consumes substantial cash and remains deeply loss-making, meaning growth has not yet translated into self-funded operations. Continued investment and delayed breakeven could erode cash reserves or increase future financing dependence.
Product Roadmap Delays And Transition RiskDelays and product withdrawals can weaken near-term placement momentum and postpone expected performance gains from newer platforms. The transition from P2 Solo to P2i also creates conversion risk across the installed customer base.
China And APAC Commercial HeadwindsExport restrictions, stronger local competition and contract loss can limit regional instrument placements and consumable pull-through. These pressures may also reduce geographic diversification and make the company's growth outlook more dependent on the Americas.
ONTTF FAQ
What was Oxford Nanopore Technologies PLC’s price range in the past 12 months?
Oxford Nanopore Technologies PLC lowest stock price was $1.27 and its highest was $3.11 in the past 12 months.
What is Oxford Nanopore Technologies PLC’s market cap?
Oxford Nanopore Technologies PLC’s market cap is $1.64B.
When is Oxford Nanopore Technologies PLC’s upcoming earnings report date?
Oxford Nanopore Technologies PLC’s upcoming earnings report date is Aug 19, 2026 which is today.
How were Oxford Nanopore Technologies PLC’s earnings last quarter?
Currently, no data Available
Is Oxford Nanopore Technologies PLC overvalued?
According to Wall Street analysts Oxford Nanopore Technologies PLC’s price is currently Undervalued.
Does Oxford Nanopore Technologies PLC pay dividends?
Oxford Nanopore Technologies PLC does not currently pay dividends.
What is Oxford Nanopore Technologies PLC’s EPS estimate?
Oxford Nanopore Technologies PLC’s EPS estimate is -0.09.
How many shares outstanding does Oxford Nanopore Technologies PLC have?
Oxford Nanopore Technologies PLC has 975,364,100 shares outstanding.
What happened to Oxford Nanopore Technologies PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Oxford Nanopore Technologies PLC?
Currently, no hedge funds are holding shares in ONTTF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Oxford Nanopore Technologies PLC Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$2.60 (76.79% Upside)
$2.60 (76.79% Upside)
Blogger Sentiment
Bullish
ONTTF Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $33.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.08%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-15.57%
Trailing 12-Months
Company Description
Oxford Nanopore Technologies PLC
Oxford Nanopore Technologies plc, founded in 2005 and originally known as Oxford NanoLabs Limited before its name change in May 2008, is a United Kingdom-based enterprise that specializes in developing and commercializing an innovative system for analyzing diverse molecular structures through nanopore-based sensing. Its product range features a variety of devices, including the portable MinION for sequencing deoxyribonucleic acid and ribonucleic acid, and the MinION Mk1C, which integrates basecalling, data analysis, touchscreen controls, and wireless connectivity. For benchtop operations, the company offers the GridION, capable of running and analyzing up to five MinION or Flongle flow cells, as well as the GridION Mk1 nanopore sequencer. High-yield sequencing is made accessible with the PromethION 2 Solo and PromethION 2, while the PromethION 24 and PromethION 48 provide benchtop nanopore sequencers for multiple users to achieve multi-sample and multi-experiment results. Further complementing these devices are Flongle, an adapter for MinION or GridION units, and VolTRAX, a USB-powered tool designed to automate laboratory processes preceding nanopore sequencing. The company also provides a suite of software solutions: MinKNOW facilitates data acquisition, real-time analysis and feedback, local basecalling, and data streaming; specialized Basecalling tools pinpoint the identity and sequence of bases on DNA/RNA molecules; EPI2ME is a cloud-based platform for comprehensive, real-time analysis of nanopore data; and EPI2ME Labs offers bioinformatics support to help users refine their skills and confidence in analyzing their sequencing data. Additionally, Oxford Nanopore Technologies is actively developing new products such as MinION Mk1D, Ubi, Plongle, and SmidgION. All of its products are available for purchase online.
ONTTF Stock 12 Month Forecast
Average Price Target
$2.60
▲(76.79% Upside)
Avacta Group plc
―
Bioventix
―
Oxford BioDynamics
―
4basebio UK Societas
―
Aptamer Group Plc
―
Ownership Overview
0.08% Insiders
2.44% Mutual Funds
0.01% Other Institutional Investors
93.97% Public Companies and
Individual Investors









